Westchester, ILNCT07759245Now EnrollingIRB Ready

Pulmonary Disease, Chronic Obstructive Clinical Trial in Westchester, IL

Access cutting-edge pulmonary disease, chronic obstructive treatment through this phase 2 clinical trial at a research site in Westchester. Study-provided care at no cost to qualified participants.

Sponsored by Eli Lilly and Company

Quick Self-Assessment

See if you qualify for this Westchester location

Preparing your pre-screening questions…

Expert Care in Westchester

Access pulmonary disease, chronic obstructive specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related pulmonary disease, chronic obstructive treatment provided free

Apply for This Westchester Location

Check if you qualify for this pulmonary disease, chronic obstructive clinical trial in Westchester, IL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Westchester

    Convenient for IL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Westchester site if eligible
  4. 4Begin participation

About This Pulmonary Disease, Chronic Obstructive Study in Westchester

The main purpose of this study is to assess if different dose levels of Brenipatide are safe and work the way they are intended to work in participants with moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD), when compared with placebo. The study will last approximately one year.

Sponsor: Eli Lilly and Company

Who Can Participate

Inclusion Criteria

Have a physician diagnosis of Chronic Obstructive Pulmonary Disease (COPD), at least 12 months prior to screening who meet the following criteria:
Current or former smokers with a smoking history of greater than or equal to (≥) 10 pack-years
Moderate-to-severe COPD (post-Bronchodilator (BD) Forced Expiratory Volume in 1 Second (FEV₁)/forced vital capacity (FVC) less than (\<) 70 percent (%)
Modified Medical Research Council Dyspnea Scale (mMRC-DS) grade ≥2
Exacerbation history of ≥2 moderate or ≥1 severe exacerbations within the year prior to inclusion.
Background double therapy \[long-acting β₂-agonists (LABA) + long-acting muscarinic antagonists (LAMA)\] or triple therapy \[inhaled corticosteroids (ICS) + LABA + LAMA)\] for 3 months prior to randomization with a stable dose of medication for ≥1 month prior to screening.

Exclusion Criteria

Have a known pre-existing, clinically important lung condition other than COPD.
Have a current or recent acute, active infection before screening and up to randomization.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Westchester?

Yes, this clinical trial (NCT07759245) has an active research site in Westchester, IL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Pulmonary Disease, Chronic Obstructive Treatment Options in Westchester, IL

If you're searching for pulmonary disease, chronic obstructive treatment options in Westchester, IL, this clinical trial (NCT07759245) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Westchester research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced pulmonary disease, chronic obstructive specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all pulmonary disease, chronic obstructive clinical trials near you to find additional studies recruiting in your area.

More Ulcerative Colitis Trials in Westchester, IL

See all ulcerative colitis clinical trials recruiting in Westchester — not just this study.

Browse Ulcerative Colitis Trials in Westchester →

Browse More Trials by Condition

Ulcerative Colitis TrialsAnkylosing Spondylitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Westchester?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Westchester, IL